Skip to main content
    M

    McKesson Corporation (MCK)

    Official site

    HEALTHCARE • MEDICAL DISTRIBUTION • NYSE

    $1105.15
    +2.34 (+0.21%)

    Market Cap: $127.33B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    McKesson Corporation (MCK) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to McKesson are Cardinal Health (CAH), Cencora (COR) and Stryker (SYK). McKesson trades at 25.9x earnings, against a median of 16.7x for the 10 of these companies with a P/E. By market cap, McKesson ranks 5th of the 13 companies on this page; Pfizer (PFE) is the largest at $164.67B.

    Peer Comparison

    MCK's ROIC of 108.2% is above the peer median of 7.7%, and its revenue growth of 7.6% is above the median of 6.1%. Its dividend yield is below the peer median of 2.86%.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    McKesson (MCK)$127.33B25.9x0.3x1.1%108.2%7.6%0.34%
    Cardinal Health Inc (CAH)$64.97B23.7x0.3x0.7%37.6%5.5%0.73%
    Cencora Inc. (COR)$68.51B19.9x0.2x1.0%20.0%5.5%0.74%
    Stryker Corporation (SYK)$117.88B21.8x4.5x13.8%11.4%7.6%1.13%
    Henry Schein Inc (HSIC)$9.53B15.5x0.7x3.1%7.7%4.0%0.00%
    CVS Health Corp (CVS)$114.32B10.6x0.3x2.6%9.0%5.4%3.00%
    Medtronic PLC (MDT)$131.57B18.0x3.5x13.9%7.5%13.7%2.80%
    Bristol-Myers Squibb Company (BMY)$129.66B10.1x2.6x18.5%13.9%6.9%4.00%
    GSK plc (GSK)$101.13B10.5x2.3x13.0%N/A4.0%3.58%
    Sanofi ADR (SNY)$116.15BN/A2.0x8.2%7.6%15.7%5.01%
    Pfizer Inc (PFE)$164.67B9.5x2.6x6.3%2.7%-0.4%5.96%
    Danaher Corporation (DHR)$163.94B27.6x6.3x16.9%5.6%8.3%0.70%
    Takeda Pharmaceutical Co Ltd ADR (TAK)$68.47BN/A2.3x0.9%5.6%6.7%2.92%
    Peer median$115.23B16.7x2.3x7.3%7.7%6.1%2.86%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to McKesson, ranked by how closely their business, size, sector and industry match. The largest group, 4 of the 12, is in Drug Manufacturers - General; the other 8 span 5 industries.

    CompanyAboutPeers
    Cardinal Health Inc (CAH)Medical Distribution
    Cardinal Health, Inc. is an American multinational health care services company.
    CAH competitors
    Cencora Inc. (COR)Medical Distribution
    CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center...
    COR competitors
    Stryker Corporation (SYK)Medical Devices
    Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan.
    SYK competitors
    Henry Schein Inc (HSIC)Medical Distribution
    Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
    HSIC competitors
    CVS Health Corp (CVS)Healthcare Plans
    CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy...
    CVS competitors
    Medtronic PLC (MDT)Medical Devices
    Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States.
    MDT competitors
    Bristol-Myers Squibb Company (BMY)Drug Manufacturers - General
    Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City.
    BMY competitors
    GSK plc (GSK)Drug Manufacturers - General
    GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines...
    GSK competitors
    Sanofi ADR (SNY)Drug Manufacturers - General
    Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe...
    SNY competitors
    Pfizer Inc (PFE)Drug Manufacturers - General
    Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City.
    PFE competitors
    Danaher Corporation (DHR)Diagnostics & Research
    Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C..
    DHR competitors
    Takeda Pharmaceutical Co Ltd ADR (TAK)Drug Manufacturers - Specialty & Generic
    Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals...
    TAK competitors

    Frequently Asked Questions About MCK

    Who are McKesson's main competitors?

    The companies most similar to McKesson include Cardinal Health (CAH), Cencora (COR), Stryker (SYK), Henry Schein (HSIC) and CVS Health (CVS), listed from the closest match.

    Who is McKesson's biggest competitor?

    Pfizer (PFE) is the largest of the similar companies at $164.67B; Cardinal Health (CAH) is the closest match by business profile, size, sector and industry.

    How does MCK stock compare with its competitors?

    MCK's P/E is 25.9x against a peer median of 16.7x; its P/S is 0.3x against a peer median of 2.3x; its net margin is 1.1% against a peer median of 7.3%.

    Which of McKesson's competitors pays a higher dividend?

    McKesson has a forward dividend yield of 0.34%. Pfizer (PFE), Sanofi ADR (SNY), Bristol-Myers Squibb Company (BMY), GSK (GSK), CVS Health (CVS), Takeda Pharmaceutical Co Ltd ADR (TAK), Medtronic (MDT), Stryker (SYK), Cencora (COR), Cardinal Health (CAH) and Danaher (DHR) have higher forward dividend yields; Pfizer (PFE) has the highest at 5.96%.

    Is McKesson bigger than its competitors?

    No. McKesson is 5th by market cap among the 13 companies on this page; the largest is Pfizer (PFE) at $164.67B.